Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).

Journal article

OBJECTIVE: Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 diabetes. We conducted a post hoc analysis to compare the efficacy and safety of atorvastatin among 1,129 patients aged 65-75 years at randomization with 1,709 younger patients in the Collaborative Atorvastatin Diabetes Study (CARDS). R...

Expand abstract

Authors: Neil, H; DeMicco, D; Luo, D; Betteridge, D; Colhoun, H

• Journal: Diabetes care
• Volume: 29
• Issue: 11
• Pages: 2378-2384
• Publication date: 2006-11-01
• DOI: 10.2337/dc06-0872
• EISSN: 1935-5548
• ISSN: 0149-5992
• Language: English
• Keywords: Angina, Unstable; Female; Risk Reduction Behavior; Adult; CARDS Study Investigators; Coronary Disease; Male; Age Distribution; Diabetes Mellitus, Type 2; Anticholesteremic Agents; Aged; Stroke; Myocardial Infarction; Risk Factors; Middle Aged; Humans; Heptanoic Acids; Pyrroles